Spotty insurance coverage for GLP-1 drugs gets worse

NPR | By Sydney Lupkin

Published April 15, 2026 at 5:39 PM EDT

Threads
Facebook
Twitter
Pinterest
Bluesky
LinkedIn
Email

Insurance coverage of blockbuster obesity drugs has been spotty at best over the years, and it looks like things are getting worse, not better. Plans are dropping coverage or restricting it further.